Related references
Note: Only part of the references are listed.Controlling Nanomaterial Size and Shape for Biomedical Applications via Polymerization-Induced Self-Assembly
Song Yang Khor et al.
MACROMOLECULAR RAPID COMMUNICATIONS (2019)
Architectural Modification of Conformal PEG-Bottlebrush Coatings Minimizes Anti-PEG Antigenicity While Preserving Stealth Properties
Daniel Y. Joh et al.
ADVANCED HEALTHCARE MATERIALS (2019)
PEGylation: a promising strategy to overcome challenges to cancer-targeted nanomedicines: a review of challenges to clinical transition and promising resolution
Zahid Hussain et al.
DRUG DELIVERY AND TRANSLATIONAL RESEARCH (2019)
Red blood cell membrane-camouflaged nanoparticles: a novel drug delivery system for antitumor application
Qing Xia et al.
ACTA PHARMACEUTICA SINICA B (2019)
Toxicity and immunogenicity concerns related to PEGylated-micelle carrier systems: a review
Kouichi Shiraishi et al.
SCIENCE AND TECHNOLOGY OF ADVANCED MATERIALS (2019)
Synthesis of amphiphilic copolymers based on dendritic polyethylene grafted by polyhydroxyethylmethacrylate and polyhydroxypropylmethacrylate and their use for construction of nanoparticles
Katerina Nunvarova et al.
EUROPEAN POLYMER JOURNAL (2019)
Conjugation of staphylokinase with the arabinogalactan-PEG conjugate: Study on the immunogenicity, in vitro bioactivity and pharmacokinetics
Fangbing Qi et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES (2019)
PEGylated liposomes: immunological responses
Marwa Mohamed et al.
SCIENCE AND TECHNOLOGY OF ADVANCED MATERIALS (2019)
A pH-responsive nanoparticle targets the neurokinin 1 receptor in endosomes to prevent chronic pain
Paulina D. Ramirez-Garcia et al.
NATURE NANOTECHNOLOGY (2019)
Effect of Kupffer cells depletion on ABC phenomenon induced by Kupffer cells-targeted liposomes
Chaoyang Lai et al.
ASIAN JOURNAL OF PHARMACEUTICAL SCIENCES (2019)
Time Interval of Two Injections and First-Dose Dependent of Accelerated Blood Clearance Phenomenon Induced by PEGylated Liposomal Gambogenic Acid: The Contribution of PEG-Specific IgM
Fengling Wang et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2019)
Anti-PEG Antibodies Inhibit the Anticoagulant Activity of PEGylated Aptamers
Angelo Moreno et al.
CELL CHEMICAL BIOLOGY (2019)
The effects of particle size, shape, density and flow characteristics on particle margination to vascular walls in cardiovascular diseases
Hang T. Ta et al.
EXPERT OPINION ON DRUG DELIVERY (2018)
Surface-adaptive zwitterionic nanoparticles for prolonged blood circulation time and enhanced cellular uptake in tumor cells
Hanlin Ou et al.
ACTA BIOMATERIALIA (2018)
PEGylation for enhancing nanoparticle diffusion in mucus
Justin T. Huckaby et al.
ADVANCED DRUG DELIVERY REVIEWS (2018)
Beyond PEGylation: Alternative surface-modification of nanoparticles with mucus-inert biomaterials
Vitaliy V. Khutoryanskiy
ADVANCED DRUG DELIVERY REVIEWS (2018)
Polypeptides with High Zwitterion Density for Safe and Effective Therapeutics
Peng Zhang et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2018)
Complement Activation by PEGylated Gold Nanoparticles
Quang Huy Quach et al.
BIOCONJUGATE CHEMISTRY (2018)
Poly(2-oxazoline)s based biomaterials: A comprehensive and critical update
Thomas Lorson et al.
BIOMATERIALS (2018)
A hydroxyl PEG version of PEGylated liposomes and its impact on anti-PEG IgM induction and on the accelerated clearance of PEGylated liposomes
Taro Shimizu et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2018)
Bioinspired Shielding Strategies for Nanoparticle Drug Delivery Applications
Neetu M. Gulati et al.
MOLECULAR PHARMACEUTICS (2018)
Understanding the Role of Anti-PEG Antibodies in the Complement Activation by Doxil in Vitro
Barry W. Neun et al.
MOLECULES (2018)
PEGylation of therapeutic oligonucletides: From linear to highly branched PEG architectures
Xueguang Lu et al.
NANO RESEARCH (2018)
Pre-existing anti-polyethylene glycol antibody reduces the therapeutic efficacy and pharmacokinetics of PEGylated liposomes
Yuan-Chin Hsieh et al.
THERANOSTICS (2018)
Overcoming Surfactant-Induced Morphology Instability of Noncrosslinked Diblock Copolymer Nano-Objects Obtained by RAFT Emulsion Polymerization
Nghia P. Truong et al.
ACS MACRO LETTERS (2018)
Impact of anti-PEG antibodies on PEGylated nanoparticles fate in vivo
Kinam Park
JOURNAL OF CONTROLLED RELEASE (2018)
Elucidating the Influences of Size, Surface Chemistry, and Dynamic Flow on Cellular Association of Nanoparticles Made by Polymerization-Induced Self-Assembly
Song Yang Khor et al.
SMALL (2018)
Zwitterlation mitigates protein bioactivity loss in vitro over PEGylation
Yanjiao Han et al.
CHEMICAL SCIENCE (2018)
PEGylation and anti-PEG antibodies
Amr S. Abu Lila et al.
ENGINEERING OF BIOMATERIALS FOR DRUG DELIVERY SYSTEMS: BEYOND POLYETHYLENE GLYCOL (2018)
Surfactant-free RAFT emulsion polymerization using a novel biocompatible thermoresponsive polymer
Nghia P. Truong et al.
POLYMER CHEMISTRY (2017)
Mechanistic understanding of in vivo protein corona formation on polymeric nanoparticles and impact on pharmacokinetics
Nicolas Bertrand et al.
NATURE COMMUNICATIONS (2017)
PEGylated graphene oxide elicits strong immunological responses despite surface passivation
Nana Luo et al.
NATURE COMMUNICATIONS (2017)
Influence of Size and Shape on the Biodistribution of Nanoparticles Prepared by Polymerization-Induced Self-Assembly
Sadik Kaga et al.
BIOMACROMOLECULES (2017)
Nanoparticle-macrophage interactions: A balance between clearance and cell-specific targeting
Rahul Rattan et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2017)
Pre-existing Antibody: Biotherapeutic Modality-Based Review
Boris Gorovits et al.
AAPS JOURNAL (2016)
PEGylation as a strategy for improving nanoparticle-based drug and gene delivery
Jung Soo Suk et al.
ADVANCED DRUG DELIVERY REVIEWS (2016)
Immediate-type hypersensitivity to polyethylene glycols: a review
E. Wenande et al.
CLINICAL AND EXPERIMENTAL ALLERGY (2016)
Polyethylene glycol (PEG): a versatile polymer for pharmaceutical applications
Anisha A. D'souza et al.
EXPERT OPINION ON DRUG DELIVERY (2016)
Pre-existing anti-polyethylene glycol antibody linked to first-exposure allergic reactions to pegnivacogin, a PEGylated RNA aptamer
Nancy J. Ganson et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2016)
Anti-PEG antibodies in the clinic: Current issues and beyond PEGylation
Peng Zhang et al.
JOURNAL OF CONTROLLED RELEASE (2016)
PEGylation of Biopharmaceuticals: A Review of Chemistry and Nonclinical Safety Information of Approved Drugs
Peter L. Turecek et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2016)
Facile production of nanoaggregates with tuneable morphologies from thermoresponsive P(DEGMA-co-HPMA)
Nghia P. Truong et al.
POLYMER CHEMISTRY (2016)
PEGylation in anti-cancer therapy: An overview
Prajna Mishra et al.
ASIAN JOURNAL OF PHARMACEUTICAL SCIENCES (2016)
Anti-PEG IgM Is a Major Contributor to the Accelerated Blood Clearance of Polyethylene Glycol-Conjugated Protein
Yu Mima et al.
MOLECULAR PHARMACEUTICS (2015)
Rapid synthesis of ultrahigh molecular weight and low polydispersity polystyrene diblock copolymers by RAFT-mediated emulsion polymerization
Nghia P. Truong et al.
POLYMER CHEMISTRY (2015)
Anti-PEG immunity: emergence, characteristics, and unaddressed questions
Qi Yang et al.
WILEY INTERDISCIPLINARY REVIEWS-NANOMEDICINE AND NANOBIOTECHNOLOGY (2015)
Carbohydrate PEGylation, an approach to improve pharmacological potency
M. Eugenia Giorgi et al.
BEILSTEIN JOURNAL OF ORGANIC CHEMISTRY (2014)
Potential induction of anti-PEG antibodies and complement activation toward PEGylated therapeutics
Johan J. F. Verhoef et al.
DRUG DISCOVERY TODAY (2014)
A noticeable phenomenon: Thiol terminal PEG enhances the immunogenicity of PEGylated emulsions injected intravenously or subcutaneously into rats
Chunling Wang et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2013)
Prolongation of time interval between doses could eliminate accelerated blood clearance phenomenon induced by pegylated liposomal topotecan
ChunLei Li et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2013)
The accelerated blood clearance (ABC) phenomenon: Clinical challenge and approaches to manage
Amr S. Abu Lila et al.
JOURNAL OF CONTROLLED RELEASE (2013)
The Immunogenicity of Polyethylene Glycol: Facts and Fiction
Huub Schellekens et al.
PHARMACEUTICAL RESEARCH (2013)
An influenza virus-inspired polymer system for the timed release of siRNA
Nghia P. Truong et al.
NATURE COMMUNICATIONS (2013)
Taking tissue adhesives to the future: from traditional synthetic to new biomimetic approaches
Ligia Pereira Bre et al.
BIOMATERIALS SCIENCE (2013)
Chemistry for peptide and protein PEGylation
M. J. Roberts et al.
ADVANCED DRUG DELIVERY REVIEWS (2012)
Best Practices in Cancer Nanotechnology: Perspective from NCI Nanotechnology Alliance
William C. Zamboni et al.
CLINICAL CANCER RESEARCH (2012)
FDA-approved poly(ethylene glycol)-protein conjugate drugs
Steevens N. S. Alconcel et al.
POLYMER CHEMISTRY (2011)
Physiologically Based Pharmacokinetic Modeling of Nanoparticles
Mingguang Lu et al.
ACS NANO (2010)
Ultralow-Fouling, Functionalizable, and Hydrolyzable Zwitterionic Materials and Their Derivatives for Biological Applications
Shaoyi Jiang et al.
ADVANCED MATERIALS (2010)
Poly(ethylene glycol) in Drug Delivery: Pros and Cons as Well as Potential Alternatives
Katrin Knop et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2010)
Anti-PEG IgM Response against PEGylated Liposomes in Mice and Rats
Masako Ichihara et al.
Pharmaceutics (2010)
Functionalizable and ultra stable nanoparticles coated with zwitterionic poly(carboxybetaine) in undiluted blood serum
Wei Yang et al.
BIOMATERIALS (2009)
Accelerated Blood Clearance Phenomenon Upon Repeated Injection of PEG-modified PLA-nanoparticles
Tsutomu Ishihara et al.
PHARMACEUTICAL RESEARCH (2009)
Anti-cancer PEG-enzymes: 30 years old, but still a current approach
Gianfranco Pasut et al.
ADVANCED DRUG DELIVERY REVIEWS (2008)
The impact of PEGylation on biological therapies
Francesco M. Veronese et al.
BIODRUGS (2008)
The pharmacology of PEGylation: Balancing PD with PK to generate novel therapeutics
C. Simone Fishburn
JOURNAL OF PHARMACEUTICAL SCIENCES (2008)
N-terminally PEGylated human interferon-beta-1a with improved pharmacokinetic properties and in vivo efficacy in a melanoma angiogenesis model
DP Baker et al.
BIOCONJUGATE CHEMISTRY (2006)
PEGylation, successful approach to drug delivery
FM Veronese et al.
DRUG DISCOVERY TODAY (2005)
Immunological properties of uricase conjugated to neutral soluble polymers
P Caliceti et al.
BIOCONJUGATE CHEMISTRY (2001)
Share Paper
